Related Experiment Video
Updated: May 30, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Changing prevalence of some selected gastrointestinal diseases vis-à-vis H. pylori infection
Bohumil Fixa1, Olga Komárková, Zdenek Nozicka
1Second Department of Medicine, Charles University Prague Medical Faculty at Hradec Králové Teaching Hospital, Hradec Králové, Czech Republic. bohumil.fixa@tiscali.cz
Background/Aims:
The aim of this prospective study was to evaluate the changing relative prevalence of peptic ulcer disease, gastroesophageal reflux disease and functional dyspepsia over 18 years (four periods) in a country with a significant decline of H. pylori prevalence.
Methodology:
In total, 3000 patients were studied. Only the first 750 consecutive dyspeptic patients in each period who were referred to endoscopy and in whom the abovementioned diseases were diagnosed were assessed. In each patient, H. pylori status was evaluated.
Results:
From 1988 to 2006, the number of peptic ulcer disease patients decreased significantly while that of reflux esophagitis patients significantly increased. Prevalence of functional disease patients continued to be high. The prevalence of H. pylori in gastroesophageal reflux disease and functional dyspepsia patients declined significantly.
Conclusions:
The results show remarkable changes in the epidemiology of peptic ulcer disease and reflux esophagitis among the population with a decrease of H. pylori prevalence. The significant decrease of H. pylori among functional dyspepsia patients, which continues to have a high prevalence, indirectly supports the opinion that the role of H. pylori is of no dominant importance in this disease. The decline of peptic ulcer disease is partially explainable by the decrease of H. pylori infection in the general population, but other factors should be established.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
